↓ Skip to main content

The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells

Overview of attention for article published in Arthritis Research & Therapy, July 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
patent
1 patent
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
207 Dimensions

Readers on

mendeley
138 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
Published in
Arthritis Research & Therapy, July 2011
DOI 10.1186/ar3400
Pubmed ID
Authors

Betty Y Chang, Min Mei Huang, Michelle Francesco, Jun Chen, Jeremy Sokolove, Padmaja Magadala, William H Robinson, Joseph J Buggy

Abstract

The aim was to determine the effect of the Bruton tyrosine kinase (Btk)-selective inhibitor PCI-32765, currently in Phase I/II studies in lymphoma trials, in arthritis and immune-complex (IC) based animal models and describe the underlying cellular mechanisms.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 134 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 42 30%
Student > Ph. D. Student 20 14%
Other 12 9%
Student > Master 9 7%
Student > Bachelor 7 5%
Other 19 14%
Unknown 29 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 33 24%
Medicine and Dentistry 28 20%
Biochemistry, Genetics and Molecular Biology 13 9%
Chemistry 13 9%
Immunology and Microbiology 6 4%
Other 13 9%
Unknown 32 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2021.
All research outputs
#2,655,926
of 25,374,917 outputs
Outputs from Arthritis Research & Therapy
#526
of 3,381 outputs
Outputs of similar age
#12,513
of 128,350 outputs
Outputs of similar age from Arthritis Research & Therapy
#5
of 43 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,350 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.